Parallax Volatility Advisers’s HCA Healthcare HCA Stock Holding History

Parallax Volatility Advisers’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,900	Closed	-$10.7M	–	1652
2025 Q4	$10.7M	Buy	22,900 +14,900	+186%	+$6.92M	0.02%	436
2025 Q3	$3.41M	Sell	8,000 -7,000	-47%	-$2.71M	0.01%	778
2025 Q2	$5.75M	Buy	15,000 +7,000	+88%	+$2.52M	0.01%	589
2025 Q1	$2.76M	Sell	8,000 -13,300	-62%	-$4.28M	0.01%	781
2024 Q4	$6.39M	Buy	21,300 +13,300	+166%	+$4.65M	0.01%	731
2024 Q3	$3.25M	Hold	8,000	–	–	0.01%	961
2024 Q2	$2.57M	Sell	8,000 -27,800	-78%	-$9.03M	0.01%	955
2024 Q1	$11.9M	Buy	35,800 +13,400	+60%	+$4.09M	0.03%	466
2023 Q4	$6.06M	Buy	22,400 +10,300	+85%	+$2.55M	0.01%	768
2023 Q3	$2.98M	Buy	12,100 +5,000	+70%	+$1.37M	0.01%	950
2023 Q2	$2.15M	Buy	7,100 +3,800	+115%	+$1.06M	﹤0.01%	1113
2023 Q1	$870K	Sell	3,300 -27,500	-89%	-$6.99M	﹤0.01%	1558
2022 Q4	$7.39M	Sell	30,800 -4,800	-13%	-$1.08M	0.01%	889
2022 Q3	$6.54M	Buy	35,600 +1,100	+3%	+$219K	0.01%	908
2022 Q2	$5.79M	Buy	34,500 +3,500	+11%	+$752K	0.01%	922
2022 Q1	$7.77M	Buy	31,000 +13,400	+76%	+$3.36M	﹤0.01%	835
2021 Q4	$4.52M	Sell	17,600 -7,400	-30%	-$1.81M	﹤0.01%	1247
2021 Q3	$6.07M	Buy	25,000 +17,500	+233%	+$4.28M	﹤0.01%	1158
2021 Q2	$1.55M	Sell	7,500 -49,600	-87%	-$10.1M	﹤0.01%	1748
2021 Q1	$10.8M	Sell	57,100 -109,300	-66%	-$19.3M	0.01%	911
2020 Q4	$27.4M	Sell	166,400 -187,200	-53%	-$27.4M	0.02%	645
2020 Q3	$44.1M	Buy	353,600 +129,200	+58%	+$16M	0.03%	437
2020 Q2	$21.8M	Buy	224,400 +71,500	+47%	+$7.43M	0.03%	496
2020 Q1	$13.7M	Buy	152,900 +147,400	+2,680%	+$19.1M	0.02%	497
2019 Q4	$813K	Buy	5,500 +3,600	+189%	+$483K	﹤0.01%	1583
2019 Q3	$229K	Buy	+1,900	New	+$246K	﹤0.01%	1823
2019 Q1	–	Sell	-4,600	Closed	-$571K	–	3266
2018 Q4	$571K	Buy	+4,600	New	+$617K	﹤0.01%	1468
2018 Q1	–	Sell	-281,500	Closed	-$24.7M	–	3064
2017 Q4	$24.7M	Buy	281,500 +150,000	+114%	+$12.1M	0.03%	221
2017 Q3	$10.5M	Buy	+131,500	New	+$10.6M	0.02%	394
2017 Q2	–	Sell	-153,400	Closed	-$13.7M	–	2945
2017 Q1	$13.7M	Buy	153,400 +128,400	+514%	+$10.7M	0.03%	316
2016 Q4	$1.85M	Sell	25,000 -1,428,000	-98%	-$107M	﹤0.01%	1001
2016 Q3	$110M	Buy	+1,453,000	New	+$111M	0.2%	59
2016 Q2	–	Sell	-1,400	Closed	-$109K	–	2913
2016 Q1	$109K	Sell	1,400 -70,800	-98%	-$4.94M	﹤0.01%	1943
2015 Q4	$4.88M	Sell	72,200 -15,200	-17%	-$1.06M	0.01%	693
2015 Q3	$6.76M	Buy	87,400 +38,200	+78%	+$3.38M	0.02%	588
2015 Q2	$4.46M	Buy	49,200 +6,700	+16%	+$537K	0.01%	753
2015 Q1	$3.2M	Buy	42,500 +28,700	+208%	+$2.06M	0.01%	884
2014 Q4	$1.01M	Sell	13,800 -107,600	-89%	-$7.56M	﹤0.01%	1504
2014 Q3	$8.56M	Buy	121,400 +113,400	+1,418%	+$7.49M	0.03%	514
2014 Q2	$451K	Buy	8,000 +2,000	+33%	+$106K	﹤0.01%	1441
2014 Q1	$317K	Buy	6,000 +1,800	+43%	+$89.6K	﹤0.01%	1219
2013 Q4	$201K	Sell	4,200 -3,500	-45%	-$162K	﹤0.01%	1469
2013 Q3	$328K	Sell	7,700 -5,400	-41%	-$211K	﹤0.01%	937
2013 Q2	$471K	Buy	+13,100	New	+$507K	﹤0.01%	841

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Parallax Volatility Advisers's HCA Position: Q2 2025 in Review

Parallax Volatility Advisers sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 2 shares — an estimated $721 sold.

Parallax Volatility Advisers first reported a position in HCA in Q2 2013 and held it in 30 quarters. The position peaked at $8.99M in Q2 2020. 1,250 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

Parallax Volatility Advisers reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
Parallax Volatility Advisers sold 2 HCA Healthcare shares in Q2 2025, an estimated $721.
Parallax Volatility Advisers first reported a position in HCA Healthcare in Q2 2013 and held it in 30 quarters.
Parallax Volatility Advisers's HCA Healthcare position peaked at $8.99M in Q2 2020.
1,250 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Parallax Volatility Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.